Orchard therapeutics plc (ORTX)
Balance Sheet / Yearly
Mar'20Dec'19Dec'18
Assets
Current assets:
Cash and cash equivalents

27,098

19,053

335,844

Marketable securities

236,767

305,937

-

Trade receivables

709

1,442

2,103

Prepaid expenses and other current assets

19,547

8,530

6,985

Research and development tax credit receivable, current

14,047

14,934

10,585

Total current assets

298,168

349,896

355,517

Non-current assets:
Operating lease right-of-use-assets

21,932

19,415

-

Property and equipment, net

8,679

7,596

5,476

Research and development tax credit receivable

16,164

13,710

-

Restricted cash

4,266

4,264

3,837

Other assets

5,638

4,400

1,212

Total non-current assets

-

-

10,525

Total assets

354,847

399,281

366,042

Liabilities and shareholders’ equity
Current liabilities:
Accounts payable

13,479

11,984

18,125

Accrued expenses and other current liabilities

25,122

37,980

29,780

Operating lease liabilities

6,202

5,892

-

Total current liabilities

44,803

55,856

47,905

Long-term debt, net

24,794

24,699

-

Operating lease liabilities, net of current portion

17,492

15,320

-

Other long-term liabilities

3,204

4,213

6,799

Total liabilities

90,293

100,088

54,704

Shareholders’ equity:
Ordinary shares, £0.10 nominal value

12,361

12,331

10,924

Additional paid-in capital

749,368

738,481

587,490

Accumulated other comprehensive income

7,055

2,042

3,163

Accumulated deficit

-504,200

-453,661

-290,239

Total shareholders’ equity

264,554

299,193

311,338

Total liabilities and shareholders’ equity

354,847

399,281

366,042